MedPath

The impact of oral probiotics on vaginal Group B Streptococcal colonization rates on Group B Streptococcus (GBS)-positive pregnant wome

Phase 3
Recruiting
Conditions
Streptococcus group B in pregnant women.
Streptococcus B carrier state complicating pregnancy
099.820
Registration Number
IRCT20211012052737N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
64
Inclusion Criteria

Patient consent to participate in this study
Pregnant women over 18 years of age who are diagnosed with GBS based on physical examination, clinical and laboratory signs.
Having a positive culture of vaginal / rectal secretions for group B streptococci
Gestational age 36 weeks and less

Exclusion Criteria

Preeclampsia or gestational diabetes or other diseases
Termination of pregnancy earlier than 38 weeks of gestation
Absolute bed rest of the patient
Taking antibiotics during the intervention and one week before it

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of group B streptococcus. Timepoint: 1 month after intervention. Method of measurement: Positive culture test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath